Nomad Power Solutions (NMAD) Net Shares Issued and Repurchased (2024 - 2025)
Nomad Power Solutions (NMAD) posted Net Shares Issued and Repurchased of $500000.0 for Q4 2025, up 1478.98% on a QoQ basis from $31666.0 in Q4 2024, and up 1478.98% year-over-year from $31666.0 in Q4 2024.
Powered by 
Analysis
Nomad Power Solutions (NMAD) Net Shares Issued and Repurchased (2024 - 2025) Analysis & Trends
Nomad Power Solutions has reported Net Shares Issued and Repurchased for 2 years, with the latest figure at $500000.0 in Q4 2025.
- On a quarterly basis, Net Shares Issued and Repurchased rose 1478.98% year-over-year to $500000.0 in Q4 2025; TTM through Dec 2025 was $500000.0, a 1478.98% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 3931.83% from the prior year.
- Net Shares Issued and Repurchased was $500000.0 for Q4 2025 at Nomad Power Solutions, up from $31666.0 in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $500000.0 in Q4 2025, with the low at $31666.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Nomad Power Solutions | 49.59 Mn | 49.59 Mn | - | - |